Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Acromegaly Market Size Changed, over the years?

The expansion of the acromegaly market has been swift in the past few years. The expectation is that it will escalate from $2.15 billion in 2024 to $2.57 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 19.6%. The growth experienced during the historic period can be accredited to factors such as a rise in the prevalence of acromegaly therapeutics, increased acromegaly awareness, government initiatives, and the demand for efficient treatments.

How Much Will the Acromegaly Market Be Worth in 2029?

In the upcoming years, a swift expansion is predicted for the acromegaly industry, with market size potentially amassing $4.92 billion by 2029 at a compound annual growth rate (CAGR) of 17.6%. This progression in the forecast period might be due to higher investment in the research and development of acromegaly treatments, increased frequency of screening programs, growing healthcare expenditure, and a surge in preference for minimally invasive treatment alternatives. The forecast period is marked by emerging trends such as groundbreaking treatments for acromegaly, the evolution of targeted therapies specifically for acromegaly, a robust drug pipeline, enhancements in treatment choices, and sophisticated personalized medicine.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12913&type=smp

Which is the Largest Company in the Acromegaly Market?

Major companies operating in the acromegaly market are Pfizer Inc., Johnson & Johnson Private Limited, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, GlaxoSmithKline PLC, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH., Amgen Inc., Allergan Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Ipsen Pharma S.A., Hikma Pharmaceuticals PLC, Lupin Ltd., Recordati S.p.A., Ionis Pharmaceuticals Inc., Amryt Pharma plc, Strongbridge Biopharma PLC, Aquestive Therapeutics Inc., Peptron Inc., Crinetics Pharmaceuticals, Chiasma Inc.

What Are the Main Market Drivers in the Acromegaly Industry?

The continued rise in hormonal disorders like diabetes is poised to boost the acromegaly market’s growth. Referred to medically as endocrine disorders, these diseases result from malfunctions within the endocrine system, with diabetes being a significant and common hormonal disease. Both acromegaly and other endocrine disorders can stem from excessive hormone production, such as growth hormone or cortisol. What’s more, high levels of growth hormone can affect insulin synthesis, leading around half of those with acromegaly to develop insulin resistance or type 2 diabetes mellitus. For example, the Office for Health Improvement and Disparities, a UK government department, reported in March 2024 that from March 2022 to March 2023, there was a 22% increase in individuals with type 1 diabetes receiving all eight recommended care processes, a 21% increase for type 2 diabetes, and a peak of 37.9% achieving target HbA1c levels as per the National Diabetes Audit (NDA). Hence, the surge in hormonal diseases is fuelling the growth of the acromegaly market.

Acromegaly Market Driver: The Influence of Genetic Abnormalities on The Growth of The Acromegaly Market

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12913&type=smp

How Is the Acromegaly Market Segments Structured?

The acromegaly market covered in this report is segmented –

1) By Type: Ectopic Acromegaly, Acromegaly Due To Growth Hormone

2) By Diagnosis: GH And IGF-I Measurement, Growth Hormone Suppression Test, Imaging, Other Diagnosis

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations

4) By Treatment: Medication, Somatostatin analogues, Dopamine Agonists, Growth Hormone Antagonist, Surgery, Radiation, Other Treatments

5) By End Users: Hospitals, Specialty Clinics, Homecare, Other End Users

Subsegments:

1) By Ectopic Acromegaly: Tumor-Induced Ectopic Acromegaly, Non-Tumor-Induced Ectopic Acromegaly

2) By Acromegaly Due To Growth Hormone: Primary Growth Hormone Excess, Secondary Growth Hormone Excess

What Strategic Trends Are Transforming the Acromegaly Market?

Key players in the acromegaly market are concentrating on creating innovative products and solutions, like generic lanreotide, to augment treatment choices and better patient results. Generic lanreotide is an unbranded version of the medication used for managing acromegaly and certain neuroendocrine tumors, functioning as a somatostatin analogue that minimizes growth hormone secretion and enhances patient access to effective treatments. For instance, in October 2024, Teva Pharmaceutical Industries Ltd., an Israel-based pharmaceutical firm with a focus on generic drugs, introduced the one and only generic version of Sandostatin LAR Depot in the United States. The injected suspension, octreotide acetate, is used to manage acromegaly and severe diarrhea related to carcinoid syndrome. This product’s introduction increases the availability of essential treatment for patients needing such therapies.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/acromegaly-global-market-report

Which Global Regions Offer the Highest Growth in the Acromegaly Market?

North America was the largest region in the acromegaly market in 2024. The regions covered in acromegaly market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12913

This Report Delivers Insight On:

1. How big is the acromegaly market, and how is it changing globally?

2. Who are the major companies in the acromegaly market, and how are they performing?

3. What are the key opportunities and risks in the acromegaly market right now?

4. Which products or customer segments are growing the most in the acromegaly market?

5. What factors are helping or slowing down the growth of the acromegaly market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model